Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.060
-0.050 (-2.37%)
Aug 4, 2026, 12:36 PM EDT - Market open

Lipocine Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.571.9811.23.070.5-
Revenue Growth
409.37%-82.35%264.67%514.16%--
Gross Profit
1.571.9811.23.070.5-
Operating Income
-12.57-10.37-1.16-17.93-12.123.15
Net Income
-9.48-9.630.01-16.35-10.76-0.63
Earnings Per Share
-1.87-1.77--3.14-2.15-0.17
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
23.2714.9321.6322.0432.5344.62
Total Debt
000002.31
Net Cash (Debt)
23.2714.9321.6322.0432.5342.31
Net Cash Growth
29.72%-30.98%-1.82%-32.26%-23.11%200.54%
Net Cash Per Share
3.432.623.994.186.198.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.19-9.76-1.22-11.87-11.97-4.41
Capital Expenditures
---0.09-0.01-0.13-0.01
Free Cash Flow
-11.19-9.76-1.31-11.88-12.1-4.42
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-800.82%-524.69%-10.31%-583.92%-2423.87%-
Pretax Margin
-755.11%-487.04%0.08%-532.48%-2151.59%-
Profit Margin
-755.13%-487.05%0.07%-532.50%-2151.73%-
FCF Margin
-713.03%-493.79%-11.71%-386.84%-2420.53%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-7.757.757.757.757.75
PS Ratio
11.0825.022.334.8370.50-